The 5th Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application and 4th Annual Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care™ virtual conferences feature premiere access to world-renowned experts delivering evidence-based presentations on cancer management and treatment strategies in real time
December 10, 2020 03:29 PM Eastern Standard Time
CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource (PER), is leading the industry this month with two high-impact, continuing medical education–certified interactive annual conferences on cancer management on Saturday, Dec. 12.
These virtual conferences will deliver value for oncologists across cancer tumor types. Clinicians can kick-start their day hearing expert perspectives on the advantages of currently available liquid-based and tissue-based testing approaches and continue their day discussing new and emerging tumor biomarkers that drive personalized treatment with oncology immunotherapies with world-renowned oncology experts.
“PER® is committed to producing specific, impactful programming to help health care professionals stay up to date on the latest data, biomarkers and patient care strategies,” said Phil Talamo, CHCP, president of PER®. “Throughout these two highly anticipated cutting-edge virtual conferences, our learners will be able to attend specific tumor type sessions and discuss cancer management strategies in real time with expert faculty.”
The PER® cancer management interactive virtual conferences on Dec. 12 are:
- 4th Annual Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care™ will be a live conference led by returning co-chair Benjamin P. Levy, M.D. In this innovative half-day program, health care professionals will learn about current applications and examine emerging developments, all aimed at individualizing treatment for patients with cancer. To register, click here.
- 5th Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application will be a full-day, live conference led by returning co-chairs Naiyer Rizvi, M.D., and Mario Sznol, M.D. Using a mix of brief presentations, panel discussions and case reviews, this meeting will engage participants and provide clinicians with immunotherapeutic strategies based on emerging data. These strategies can be directly applied to day-to-day management of lung cancers, melanoma, genitourinary cancers and hematologic malignancies. To register, click here.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now advances patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While expanding into topics outside of oncology, PER® stands as the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.
PER® Media Contact
Alexandra Ventura, 609-716-7777